| Net income (loss) | -1.51M |
| Depreciation and amortization | 5.76M |
| Deferred compensation and other | |
| Loss on disposal of fixed assets | 30.24K |
| Stock compensation expense | 271.52K |
| Receivables | -6.74M |
| Inventories | -2.93M |
| Other current assets | -1.18M |
| Other assets | 20.56K |
| Accounts payable | 5.76M |
| Accrued and other liabilities | 2.01M |
| Net cash (used in) provided by operating activities | 2.54M |
| Purchase of fixed assets | -5.18M |
| Investment in trademarks and patents | 0 |
| Proceeds from sale of fixed assets | 31.18K |
| Net cash used in investing activities | -5.15M |
| Proceeds from revolving credit facility | |
| Repayments of revolving credit facility | |
| Debt financing costs | |
| Repayments of long-term debt | -54.71M |
| Issuance of common stock, net of issuance costs | |
| Proceeds from exercise of stock options | 0 |
| Net cash provided by (used in) financing activities | 3.15M |
| INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 535.07K |
| CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD | 3.41M |
| CASH AND CASH EQUIVALENTS, END OF PERIOD | 3.94M |